Elicio Therapeutics Inc.

NASDAQ: ELTX · Real-Time Price · USD
11.69
1.85 (18.80%)
At close: Aug 18, 2025, 1:44 PM

Elicio Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-51.9M -35.2M -28.21M -26.4M
Depreciation & Amortization
1.18M 1.17M 1.06M 251.45K
Stock-Based Compensation
1.45M 1.18M 579K 617.76K
Other Working Capital
7.29M -80K -1.27M 842.21K
Other Non-Cash Items
8.24M 209K 3.6M 667.05K
Deferred Income Tax
n/a n/a 947.42K 52.96K
Change in Working Capital
3.96M -57K -150K 872.43K
Operating Cash Flow
-37.07M -32.69M -22.18M -23.94M
Capital Expenditures
-87K -66K -654K -525.36K
Cash Acquisitions
3K n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 34K n/a n/a
Investing Cash Flow
-84K -32K -654K -525.36K
Debt Repayment
19.73M 10M n/a 14.03M
Common Stock Repurchased
-549K -150K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
16.96M 21.76M 82K 314.88K
Financial Cash Flow
42.32M 38.61M 21.2M 19.39M
Net Cash Flow
5.19M 5.89M -1.63M -5.07M
Free Cash Flow
-37.16M -32.76M -22.83M -24.46M